Skip to main navigation Skip to search Skip to main content

Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries

  • A Cortellini
  • , GM Dettorre
  • , U Dafni
  • , J Aguilar-Company
  • , L Castelo-Branco
  • , M Lambertini
  • , S Gennatas
  • , V Angelis
  • , A Sita-Lumsden
  • , J Rogado
  • , P Pedrazzoli
  • , D Viñal
  • , A Prat
  • , M Rossi
  • , R Berardi
  • , T Alonso-Gordoa
  • , S Grisanti
  • , G Dimopoulou
  • , P Queirolo
  • , S Pradervand
  • A Bertuzzi, M Bower, D Arnold, R Salazar, M Tucci, KJ Harrington, F Mazzoni, U Mukherjee, Z Tsourti, O Michielin, F Pommeret, J Brunet, B Vincenzi, G Tonini, A Patriarca, F Biello, Marco KRENGLI, J Tabernero, G Pentheroudakis, Alessandra Gennari, S Peters, E Romano, David James PINATO

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalJournal for ImmunoTherapy of Cancer
Volume10
Issue number11
DOIs
Publication statusPublished - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this